Development & manufacture of oral & topical dosage forms - novobiocin capsule production base (task 1) 12 months & option 1 (task 2) a cgmp batch shelf-life study 36 months PRB

Ended Awarded Last action

Contract number
75N91021F00107
Awardee
Awarding agency
Obligated
$505,500

Award facts

Opportunity
  • TORFPDCTD20211115 Solicitation number
Contract value 100% obligated
$505,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Terminate for Convenience P00003 -$85,000
Exercise an Option P00002 · Exercise optional task 3 and extend POP accordingly $186,000
Supplemental Agreement for work within scope P00001 · This modification is written to: extend the period of performance (POP) of the contract for the base task 1 cgmp batch to april 15, 2021 - july 14, 2022 at no… -$8,000
Original award $412,500

About this award

This is a delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Societal Cdmo San Diego, LLC, a small disadvantaged business contract development and manufacturing organization (CDMO). The $505,500.00 contract is for the development and manufacture of a novobiocin capsule product, including a 36-month shelf-life study, in support of NIH's cancer research programs. The award is issued under the Drug Formulation and Manufacturing Contracts 2019 indefinite delivery contract vehicle. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75N91021F00107?

75N91021F00107 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on April 19, 2021.

How much is contract 75N91021F00107 worth?

The government has obligated $505,500 on 75N91021F00107.

Is contract 75N91021F00107 an order under another contract?

Yes. 75N91021F00107 is a delivery order under 75N98019D00058, an indefinite delivery contract, on Drug Formulation and Manufacturing Contracts 2019.

Was contract 75N91021F00107 competed?

The extent of competition for 75N91021F00107 was full and open competition after exclusion of sources. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award